发展过敏性鼻炎及其对喘的影响的方法 (ARIA-EAACI 2024-2025指南:从证据到决策框架到数字化共享决策算法)
Jean Bousquet1,2,3, Bernardo Sousa-Pinto4,5, Rafael José Vieira4,5
1Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Allergy
|November 21, 2025
概括
过敏性鼻炎及其对喘的影响 (ARIA) 准则正在2024-2025年与EAACI更新,重点关注过敏性鼻炎的管理. 这个新的代使用人工智能和患者数据,以实现以人为中心,数字化支持的护理途径.
科学领域:
- 过敏和临床免疫学
- 数字健康数字健康
- 基于证据的医学基于证据的医学.
背景情况:
- 自1999年以来,过敏性鼻炎及其对喘的影响 (ARIA) 准则经历了多次修订.
- 一个新的ARIA指南代 (ARIA 2024-2025) 正在与欧洲过敏和临床免疫学会 (EAACI) 合作开发中.
研究的目的:
- 概述开发以人为中心,数字化支持和人工智能辅助的ARIA-EAACI 2024-2025指南的方法.
- 详细说明指南问题开发,证据采购和数字化护理途径创建的流程.
主要方法:
- 使用GRADE框架和EAACI的认可.
- 采用基于人工智能的工具来分析网页搜索和生成指导性问题,以及调查关键论领袖.
- 使用证据到决策 (EtD) 框架评估优先级指南问题,结合多种证据来源,包括患者生成的数据和行星健康考虑.
主要成果:
- 该方法方便通过EtD框架的12个标准系统和透明地制定建议.
- 证据来源超越随机对照试验,包括患者生成的数据,确保关注患者的观点.
- 这些指导方针将支持数字化决策算法和过敏性鼻炎管理的护理途径的开发.
结论:
- 该ARIA-EAACI 2024-2025指南代表了一种新的,以人为中心的方法来管理过敏性鼻炎.
- 人工智能,患者生成的数据和行星健康原则的整合意味着指南开发中的前性进化.
- 由此产生的数字化工具旨在加强为临床医生和患者基于证据的建议的实际应用.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:29Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
01:26Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K